Published March 2, 2018
| Version v1
Dataset
Open
The process of HDAC11 Assay Development: a kit-free method
Description
In order to develop an assay for HDAC11, a kit-free method is being attempted wherein Boc-Lys-(TFA)-AMC, a previously reported substrate was used to check the activity of HDAC11 in a preliminary experiment.
Notes
The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Files
2march2018-HDAC11 assay deve process-new substrate.pdf
Files
(179.2 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:8074f2a4423bdd453c7b8b7fad0612ec
|
179.2 kB | Preview Download |